PAUL W SANDMAN Insider Trading $PDLI PDL BIOPHARMA, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL W SANDMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL W SANDMAN. PAUL W SANDMAN is EVP and General Counsel in BOSTON SCIENTIFIC CORP ($BSX) and SVP and General Counsel in BOSTON SCIENTIFIC CORP ($BSX) and Director in PDL BIOPHARMA, INC. ($PDLI).

PAUL W SANDMAN in PDL BIOPHARMA, INC.

Trading Symbol: PDLI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL W SANDMAN: Director
Holdings: 262,800 shares
Current Value: $580,788
Latest Transaction: Jun 24 2019
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL W SANDMAN in PDL BIOPHARMA, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BSX, PDLI

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 24 2019PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorOption ExerciseA3.00126,050378,150126,050
Jun 24 2019PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorOption ExerciseA3.00126,050378,150126,050
Jun 12 2018PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorGrantA2.7654,348150,000262,800208.5 K to 262.8 K (+26.07 %)
Jun 12 2017PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorGrantA2.4760,729150,001208,452147.7 K to 208.5 K (+41.11 %)
Jun 03 2016PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorGrantA3.5271,023250,001147,72376.7 K to 147.7 K (+92.60 %)
May 29 2015PDLIPDL BIOPHARMA, INC ...Sandman Paul WDirectorGrantA6.8022,059150,00176,70054.6 K to 76.7 K (+40.37 %)

Page:   1